Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare diseases, respiratory diseases, and women's health. It has collaboration agreements with Bayer; Lilly; Almirall; Chinook Therapeutics; Novo Nordisk A/S; Galapagos; Pfizer Inc.; CONBA Pharmaceutical Co., Ltd.; Bristol Myers Squibb Company; Zhejiang JingXin Pharmaceutical Co., Ltd; Janseen Biotech; Kazia Therapeutics; Apeiron Biologics; and Takeda Pharmaceuticals. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.

Bitcoin Depot Inc. owns and operates a network of cryptocurrency kiosks in North America. It provides users to buy and sell bitcoin, litecoin, and ethereum cryptocurrencies; and engages in the sale of cryptocurrency to consumers at a network of retail locations through its BDCheckout product offering and through its website over the counter trade. The company was founded in 2016 and is headquartered in Atlanta, Georgia. Bitcoin Depot Inc. is a subsidiary of BT Assets, Inc.

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Performance Shipping Inc. provides shipping transportation services through its tanker vessels worldwide. As of December 31, 2022, its fleet consisted of eight Aframax tanker vessels with a combined carrying capacity of 851,825 DWT. The company was incorporated in 2010 and is based in Athens, Greece.

CF Acquisition Corp. VIII does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus its search on companies operating in the financial services, healthcare, real estate services, technology, and software industries. CF Acquisition Corp. VIII was incorporated in 2020 and is based in New York, New York.

36Kr Holdings Inc. provides content and business services in the People's Republic of China. It creates and distributes various content, including insightful reports on companies and timely market updates, as well as editorials and commentaries in various industries, such as technology, media and entertainment, consumer, retail, and healthcare. The company's business services include online advertising services; enterprise value-added services, such as integrated marketing, advertisement agent, offline events, and consulting services; and subscription services to individuals, institutional investors, and enterprises. 36Kr Holdings Inc. was founded in 2010 and is headquartered in Beijing, the People's Republic of China.

Hanryu Holdings, Inc. operates FANTOO, an online social media platform that connects users worldwide that share similar interests. Its platform allows users to interact with other like-minded users to share their appreciation of various types of entertainment and cultures, create and monetize their content, enjoy other users content, engage in commerce, and experience a fandom community. The company was founded in 2018 and is based in Seoul, South Korea.

Brandywine Realty Trust (NYSE: BDN) is one of the largest, publicly traded, full-service, integrated real estate companies in the United States with a core focus in the Philadelphia and Austin markets. Organized as a real estate investment trust (REIT), we own, develop, lease and manage an urban, town center and transit-oriented portfolio comprising 162 properties and 22.8 million square feet as of June 30, 2023 which excludes assets held for sale. Our purpose is to shape, connect and inspire the world around us through our expertise, the relationships we foster, the communities in which we live and work, and the history we build together.

NextPlat Corp, together with its subsidiaries, provides mobile satellite services (MSS) solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and Internet of Things (IoT) connectivity services in Europe, North America, South America, the Asia & Pacific, and Africa. It offers satellite communications products, which enable users to make voice calls, send and receive text messages and emails, and transmit GPS location coordinates virtually; GPS enabled emergency locator distress beacons that enables essential communication between customers, and search and rescue organizations during emergency situations and pinpoint locational information to search and rescue services; and SolarTrack, an IoT tracking device powered by the sun for tracking and monitoring anything that moves or remote asset used outdoors. The company also offers GTCTrack, a subscription-based mapping and tracking portal that allows managers to track, command, and control assets in near-real-time. The company provides its solutions for businesses, governments, military, humanitarian organizations, and individual users. It offers its products and services directly to end users and reseller networks; operates e-commerce websites that offer a range of MSS products and solutions; Web3, an internet service built using decentralized blockchains; NextPlat Digital enable the use of a range of digital assets, such as non-fungible tokens; and offers portable satellite voice, data, and tracking solutions through various third-party e-commerce storefronts. The company was formerly known as Orbsat Corp. and changed its name to NextPlat Corp in January 2022. NextPlat Corp is headquartered in Coconut Grove, Florida.

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. The company has a collaboration agreement with BeiGene to evaluate the safety and efficacy of Allocetra in combination with tislelizumab, an anti-PD-1 immune checkpoint inhibitor for the treatment of patients with advanced-stage solid tumors. Enlivex Therapeutics Ltd. is headquartered in Ness Ziona, Israel.